Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis (Q40561379)

21 September 2017

Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis (English)

1 reference

21 September 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

11 March 2024

author name string

A. Evdokiou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499355

11 March 2024

A. Labrinidis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499355

11 March 2024

S. Bouralexis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499355

11 March 2024

S. Hay

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499355

11 March 2024

D. M. Findlay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499355

11 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14499355

11 March 2024

publication date

1 August 2003

1 reference

full work available at URL

21 September 2017

https://api.elsevier.com/content/article/PII:S8756328203002230?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

https://api.elsevier.com/content/article/PII:S8756328203002230?httpAccept=text/plain

11 March 2024

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

11 March 2024

1 reference

21 September 2017

33

1 reference

21 September 2017

2

1 reference

21 September 2017

216-228

1 reference

Osteosarcomas and other cancers of bone

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bone mass homeostasis and bisphosphonate action

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Protein prenylation: molecular mechanisms and functional consequences

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates induce breast cancer cell death in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates induce apoptosis in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Additive antitumor activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Zoledronic acid in cancer patients with bone metastases: results of Phase I and II trials

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

1 reference

7 January 2021

Triggering caspase-independent cell death to combat cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway

16

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

Bisphosphonate treatment inhibits the growth of prostate cancer cells

11 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases

11 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

11 March 2024

Identifiers

1 reference

21 September 2017

1 reference